Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter

Your Filters

Subject : covid-19 Subject : emotional engagement
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination.

  • Authors : Talib N; Department of Medical Imaging, University Medical Imaging Toronto, University of Toronto, Toronto, Ontario, Canada.; Fronza M

Subjects: Myocarditis*/Myocarditis*/Myocarditis*/diagnostic imaging ; Myocarditis*/Myocarditis*/Myocarditis*/etiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance [J Cardiovasc Magn Reson] 2024 Summer; Vol. 26 (1), pp. 101036. Publisher: Elsevier Country of Publication: England NLM ID: 9815616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-429X

Record details

Connect Read More Add to Saved list
×
Academic Journal

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; Immunocompromised Host*/Immunocompromised Host*/Immunocompromised Host*/immunology

  • Source: The Lancet. Rheumatology [Lancet Rheumatol] 2024 Jun; Vol. 6 (6), pp. e339-e351. Date of Electronic Publication: 2024 May 08.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101765308 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines.

  • Authors : Hamm SR; Viro-Immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.; Loft JA

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Viruses [Viruses] 2024 May 28; Vol. 16 (6). Date of Electronic Publication: 2024 May 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Read More Add to Saved list
×
Academic Journal

Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.

  • Authors : Sukik L; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology

  • Source: Vaccine [Vaccine] 2024 May 22; Vol. 42 (14), pp. 3307-3320. Date of Electronic Publication: 2024 Apr 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina.

  • Authors : Garza-Silva A; Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, Mexico.; Rivera-Salinas D

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 May 14; Vol. 15, pp. 1403784. Date of Electronic Publication: 2024 May 14 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Homologous and Heterologous Covid-19 Booster Vaccinations Against SARS-CoV-2 Infection in the Elderly.

  • Authors : Acer Ö; Department of Medical Microbiology, Medical Faculty, Siirt University, 56100, Siirt, Türkiye. .; Genç Bahçe Y

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology SARS-CoV-2 variants

  • Source: Current microbiology [Curr Microbiol] 2024 May 13; Vol. 81 (7), pp. 171. Date of Electronic Publication: 2024 May 13.Publisher: Springer International Country of Publication: United States NLM ID: 7808448 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans.

  • Authors : Hellgren F; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden & Karolinska University Hospital, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

Subjects: Immunity, Innate*/Immunity, Innate*/Immunity, Innate*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: JCI insight [JCI Insight] 2024 May 08; Vol. 9 (9). Date of Electronic Publication: 2024 May 08.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies.

  • Authors : Lu X; Laboratory of Molecular Immunology, Immunology Frontier Research Center, Osaka University, Suita, Japan.; Hayashi H

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/immunology

  • Source: ELife [Elife] 2024 May 08; Vol. 12. Date of Electronic Publication: 2024 May 08.Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Editorial & Opinion

Immunogenicity of BNT162b2 vaccine after two and three doses: Correspondence.

  • Authors : Daungsupawong H; Private Academic Consultant, Phonhong, Lao Democratic People's Republic. Electronic address: .; Wiwanitkit V

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage

  • Source: Semergen [Semergen] 2024 May-Jun; Vol. 50 (4), pp. 102132. Date of Electronic Publication: 2024 Jan 30.Publisher: Saned, S.A Country of Publication: Spain NLM ID: 9610769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8865

Record details

Read More Add to Saved list
×
Academic Journal

Follow-Up and Comparative Assessment of SARS-CoV-2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA-1273 Heterologous Booster Vaccination.

  • Authors : Younes S; Biomedical Sciences Department, College of Health Sciences, Qatar University, Doha, Qatar.; Biomedical Research Center, Qatar University, Doha, Qatar.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood

  • Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 May; Vol. 18 (5), pp. e13290.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic)

Record details

Read More Add to Saved list
×